The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose

Table 3

Analysis of mean difference in postintervention outcomes of participants with impaired fasting glucose in a quasi-experimental intervention study.

	Group	Mean ± SD	t-test	value (t-test)
Fasting blood glucose (mmol/L)	Kelulut honey	0.00 ± 0.90	−0.592	0.556
	Control	0.13 ± 0.69
Total cholesterol (mmol/L)	Kelulut honey	0.08 ± 0.64	1.145	0.257
	Control	−0.11 ± 0.56
High-density lipoprotein (mmol/L)	Kelulut honey	−0.06 ± 0.23	−0.807	0.423
	Control	−0.01 ± 0.23
Low-density lipoprotein (mmol/L)	Kelulut honey	−0.10 ± 1.07	0.637	0.527
	Control	−0.25 ± 0.69
Triglycerides (mmol/L)	Kelulut honey	0.00 ± 0.57	Na	0.909
	Control	0.00 ± 0.71
Body mass index (kg/m^2)	Kelulut honey	0.62 ± 0.85	0.299	0.796
	Control	0.56 ± 0.56
Systolic blood pressure (mm/Hg)	Kelulut honey	1.07 ± 6.09	1.921	0.060
	Control	−3.11 ± 9.60
Diastolic blood pressure (mm/Hg)	Kelulut honey	0.15 ± 7.59	0.040	0.969
	Control	−0.07 ± 6.77

Median ± IQR. Mann–Whitney U-test.